[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-6550":32,"stock-themes-6550":125},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":124},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"6550","北極星藥業-KY","北極星藥業集團股份有限公司","sii","stock","生技醫療業","2022-06-06","陳賢哲","陳賢哲(暫代)",4648463440,464846344,"2006-02-09","www.polarispharma.com","P.O. Box 309 Ugland HouseGrand Cayman KY1-1104 Cayman","PG","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":63,"ret_60d":64,"ret_ytd":65,"open":63,"high":66,"low":67,"pe":68,"pb":69,"dy":70,"foreign_net_1d":71,"foreign_net_5d":72,"trust_net_1d":70,"trust_net_5d":70,"dealer_net_1d":70,"dealer_net_5d":73,"foreign_holding_pct":74,"margin_balance":70,"margin_chg":70,"short_balance":70,"short_chg":70,"large_holder_pct":75,"large_holder_chg_1w":76,"large_holder_chg_4w":77,"holders_date":78,"high_52w":79,"low_52w":80,"rev_period":81,"rev_yoy":82,"eps_period":83,"eps":84,"spark":85},15.9,-0.45000000000000107,-0.027522935779816682,-0.01851851851851838,-0.19039113027409926,515160,8240813,14227203930.000002,[60,61,62],"eps_yoy","foreign_buy_5d","holders_up",16.35,-0.35484293193717287,-0.7344691166815374,16.4,15.75,null,3.14,0,16758,148008,9000,19.78,71.54,0.2400000000000091,-1.4299999999999926,"2026-10-09",38.4,9.88,"2026-09",-52.17,"2026-Q2",-0.9470595815097732,[86,87,88,89,90,91,92,93,94,95,96,97,98,99,97,95,99,100,101,95,101,102,103,104,105,106,107,100,94,108,97,109,109,110,103,111,103,104,112,113,114,115,115,116,116,116,116,116,116,116,117,118,119,120,121,122,122,123,63,51],12.2,12.3,12.4,12.05,12.1,12,11.9,11.45,11.55,11.1,10.85,11.2,11.05,11.25,11,10.95,10.8,10.3,10.15,11.15,12.25,11.6,11.35,10.7,10.6,10.35,10.25,10.2,9.97,9.9,9.92,17.4,17.85,17.5,16.75,16.2,16.05,16.7,"20261013-fcba10",[126],{"theme":127,"segment":135,"tier":136,"role":137,"relevance":138,"note":139,"peers":140,"upstream":211,"downstream":218},{"id":128,"slug":129,"name":130,"category":131,"ret_1d":134},55,"new-drugs","新藥研發",{"slug":132,"name":133},"biotech","生技醫療",-0.025792561311777984,"新藥開發與臨床","upstream","challenger","high","癌症新藥開發",[141,155,167,178,189,201],{"code":142,"name":143,"role":144,"relevance":138,"note":145,"industry":39,"close":17,"chg_pct":146,"ret_5d":147,"ret_20d":148,"mcap":149,"turnover":150,"signals":151},"6446","藥華藥","leader","血液疾病新藥，已有上市產品",-0.016877637130801593,-0.021008403361344352,-0.11742424242424243,492134794500,1315551970,[152,153,60,154,62],"rev_yoy","rev_yoy_3m","trust_buy_5d",{"code":156,"name":157,"role":158,"relevance":138,"note":159,"industry":39,"close":160,"chg_pct":161,"ret_5d":162,"ret_20d":163,"mcap":164,"turnover":165,"signals":166},"4743","合一","niche","傷口與皮膚新藥",47.55,-0.03451776649746208,0.009554140127388422,0.04390779363336983,22849367925,83204957,[60,61,62],{"code":168,"name":169,"role":158,"relevance":138,"note":170,"industry":39,"close":171,"chg_pct":172,"ret_5d":173,"ret_20d":174,"mcap":175,"turnover":176,"signals":177},"4147","中裕","愛滋病抗體藥，已有上市產品",58.3,-0.036363636363636376,-0.028333333333333433,-0.0535714285714286,15927699919.999998,72544406,[],{"code":179,"name":180,"role":158,"relevance":138,"note":181,"industry":39,"close":182,"chg_pct":183,"ret_5d":184,"ret_20d":185,"mcap":186,"turnover":187,"signals":188},"4162","智擎","新藥開發與授權",56.5,-0.013961605584642212,0.027272727272727337,0.031021897810219023,8230784400,14152607,[152,60],{"code":190,"name":191,"role":158,"relevance":192,"note":193,"industry":39,"close":194,"chg_pct":195,"ret_5d":196,"ret_20d":197,"mcap":198,"turnover":199,"signals":200},"1760","寶齡富錦","mid","腎臟病用藥與保健品",54,-0.021739130434782594,0.0018552875695734272,-0.018181818181818077,4629906702,4998637,[152,60,61],{"code":202,"name":203,"role":137,"relevance":138,"note":139,"industry":39,"close":204,"chg_pct":205,"ret_5d":206,"ret_20d":207,"mcap":208,"turnover":209,"signals":210},"4174","浩鼎",55.8,-0.029565217391304355,0.20779220779220764,1.1338432122370938,7342146534.599999,43742268,[60],[212],{"id":213,"slug":214,"name":215,"category":216,"ret_1d":217},56,"cdmo-generics","CDMO 與學名藥",{"slug":132,"name":133},-0.010249642314885767,[]]